The Nation - News from May 9, 1986
- Share via
The Food and Drug Administration approved an antidote designed to prevent overdose deaths among the 4 million people still taking an old heart medication called Digoxin, a hard-to-regulate drug that accounts for half of all accidental poisonings among the elderly. The antidote--Digibind--can be administered intravenously in hospital emergency rooms to heart patients who take an overdose of Digoxin or a related drug, digitoxin. Digibind can also treat severe toxic reactions from non-fatal overdoses among children, the FDA said.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.